APA

Horneff G., Fitter S., Foeldvari I., Minden K., Kuemmerle-Deschner J., Tzaribacev N., Thon A., Borte M., Ganser G., Trauzeddel R. & Huppertz H. (20150721). Double-blind, placebo-controlled randomized trial with adalimumab for treatment of juvenile onset ankylosing spondylitis (JoAS): significant short term improvement. : Arthritis research & therapy.

Chicago

Horneff Gerd, Fitter Sigrid, Foeldvari Ivan, Minden Kirsten, Kuemmerle-Deschner Jasmin, Tzaribacev Nicolay, Thon Angelika, Borte Michael, Ganser Gerd, Trauzeddel Rolf and Huppertz Hans-Iko. 20150721. Double-blind, placebo-controlled randomized trial with adalimumab for treatment of juvenile onset ankylosing spondylitis (JoAS): significant short term improvement. : Arthritis research & therapy.

Harvard

Horneff G., Fitter S., Foeldvari I., Minden K., Kuemmerle-Deschner J., Tzaribacev N., Thon A., Borte M., Ganser G., Trauzeddel R. and Huppertz H. (20150721). Double-blind, placebo-controlled randomized trial with adalimumab for treatment of juvenile onset ankylosing spondylitis (JoAS): significant short term improvement. : Arthritis research & therapy.

MLA

Horneff Gerd, Fitter Sigrid, Foeldvari Ivan, Minden Kirsten, Kuemmerle-Deschner Jasmin, Tzaribacev Nicolay, Thon Angelika, Borte Michael, Ganser Gerd, Trauzeddel Rolf and Huppertz Hans-Iko. Double-blind, placebo-controlled randomized trial with adalimumab for treatment of juvenile onset ankylosing spondylitis (JoAS): significant short term improvement. : Arthritis research & therapy. 20150721.